On the public citation graph
An eye to the future: Researchers debate best path for stem cell–derived therapies
0 signed · 57 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1016/j.stemcr.2015.04.005openalex-snapshot
Treatment of Macular Degeneration Using Embryonic Stem Cell-Derived Retinal Pigment Epithelium: Preliminary Results in Asian Patients
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4818803openalex-extracted
Roles of Ipsc in Advancing Treatments for Neurological Disorders
inferred← citeshttps://doi.org/10.1002/cpsc.30openalex-snapshot
Generation of Xeno‐Free, cGMP‐Compliant Patient‐Specific iPSCs from Skin Biopsy
inferred← citeshttps://doi.org/10.1007/978-3-030-31206-0_2openalex-snapshot
Genomic Instability of iPSCs and Challenges in Their Clinical Applications
inferred← citeshttps://doi.org/10.1007/978-3-030-55359-3_1openalex-snapshot
Introduction and Basic Concepts in Stem Cell Research and Therapy: The Facts and the Hype
inferred← citeshttps://doi.org/10.1007/978-3-319-60733-7_12openalex-snapshot
Regenerative Medicine: Advances from Developmental to Degenerative Diseases
inferred← citeshttps://doi.org/10.1007/978-981-96-1261-1_24openalex-snapshot
iPSC Technology Applying in Cell Therapy
inferred← citeshttps://doi.org/10.1007/s10565-016-9372-7openalex-snapshot
The translational potential of human induced pluripotent stem cells for clinical neurology
inferred← citeshttps://doi.org/10.1007/s12015-016-9680-6openalex-snapshot
Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications
inferred← citeshttps://doi.org/10.1007/s40135-020-00244-yopenalex-snapshot
Bioengineering of Human Corneal Endothelial Cells from Single- to Four-Dimensional Cultures
inferred← citeshttps://doi.org/10.1016/b978-0-12-818084-6.00006-4openalex-snapshot
The therapeutic potential of exogenous adult stem cells for the injured central nervous system
inferred← citeshttps://doi.org/10.1016/b978-0-323-90059-1.00013-0openalex-snapshot
Signaling pathways regulate cardiovascular lineage commitment of hPSCs
inferred← citeshttps://doi.org/10.1016/b978-0-323-99892-5.00001-3openalex-snapshot
An update on clinical applications of iPSCs from a genomic point of view
inferred← citeshttps://doi.org/10.1016/b978-0-323-99987-8.00003-5openalex-snapshot
Update on stem/progenitor cell-based clinical trials for eye disease
inferred← citeshttps://doi.org/10.1016/bs.irn.2017.02.009openalex-snapshot
Effect of Chinese Herbal Medicine on Molecular Imaging of Neurological Disorders
inferred← citeshttps://doi.org/10.1016/j.ebiom.2020.103120openalex-snapshot
hESC-derived immune suppressive dendritic cells induce immune tolerance of parental hESC-derived allografts
inferred← citeshttps://doi.org/10.1016/j.eclinm.2022.101530openalex-snapshot
Myocardial regeneration protocols towards the routine clinical scenario: An unseemly path from bench to bedside
inferred← citeshttps://doi.org/10.1016/j.healun.2020.01.749openalex-snapshot
Hypoimmunogenic Derivatives of Induced Pluripotent Stem Cells Evade Immune Rejection in Fully Immunocompetent Allogeneic Recipients
inferred← citeshttps://doi.org/10.1016/j.molmed.2020.04.005openalex-snapshot
Promises and Limitations of Neural Stem Cell Therapies for Progressive Multiple Sclerosis
inferred← citeshttps://doi.org/10.1016/j.preteyeres.2018.03.005openalex-snapshot
Non-syndromic retinitis pigmentosa
inferred← citeshttps://doi.org/10.1016/j.preteyeres.2018.04.006openalex-snapshot
A new perspective on lipid research in age-related macular degeneration
inferred← citeshttps://doi.org/10.1016/j.stem.2016.09.004openalex-snapshot
Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson’s Disease
inferred← citeshttps://doi.org/10.1016/j.stem.2019.07.010openalex-snapshot
Human Pluripotent Stem Cell-Derived Cardiovascular Cells: From Developmental Biology to Therapeutic Applications
inferred← citeshttps://doi.org/10.1016/j.xjtc.2022.01.012openalex-snapshot
From genome editing to blastocyst complementation: A new horizon in heart transplantation?
inferred← citeshttps://doi.org/10.1038/s12276-025-01439-8openalex-snapshot
Tracing genomic instability in induced mesenchymal stromal cell manufacture: an integration-free transfection approach
inferred← citeshttps://doi.org/10.1038/s41419-020-02955-3openalex-snapshot
Stem/progenitor cell-based transplantation for retinal degeneration: a review of clinical trials
inferred← citeshttps://doi.org/10.1038/s41551-022-00987-yopenalex-snapshot
Challenges in the clinical advancement of cell therapies for Parkinson’s disease
inferred← citeshttps://doi.org/10.1038/s41587-019-0016-3openalex-snapshot
Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients
inferred← citeshttps://doi.org/10.1038/s41598-021-81244-1openalex-snapshot
Comparative analysis on the anti-inflammatory/immune effect of mesenchymal stem cell therapy for the treatment of pulmonary arterial hypertension
inferred← citeshttps://doi.org/10.1042/cs20220391openalex-snapshot
The negative regulation of gene expression by microRNAs as key driver of inducers and repressors of cardiomyocyte differentiation
inferred← citeshttps://doi.org/10.1080/14712598.2017.1346079openalex-snapshot
Induced pluripotent stem cell-based therapy for age-related macular degeneration
inferred← citeshttps://doi.org/10.1080/20502877.2020.1724708openalex-snapshot
Ethical Aspects of Translating Research with Human Pluripotent Stem Cell Products into Clinical Practice: A Stakeholder Approach
inferred← citeshttps://doi.org/10.1088/1758-5090/aa7e9aopenalex-snapshot
Engineering-derived approaches for iPSC preparation, expansion, differentiation and applications
inferred← citeshttps://doi.org/10.1134/s1819712421040103openalex-snapshot
Generation of TNFαR1 and ASIC1a Knockout Human Neural Stem Cells In Vitro by CRISPR/Cas9 System
inferred← citeshttps://doi.org/10.1159/000493018openalex-snapshot
Advances and Current Challenges Associated with the Use of Human Induced Pluripotent Stem Cells in Modeling Neurodegenerative Disease
inferred← citeshttps://doi.org/10.1186/s13036-022-00291-yopenalex-snapshot
Tissue engineering in age-related macular degeneration: a mini-review
inferred← citeshttps://doi.org/10.1186/s13287-022-02931-yopenalex-snapshot
Changes in best-corrected visual acuity in patients with dry age-related macular degeneration after stem cell transplantation: systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1186/s13287-022-03233-zopenalex-snapshot
Hypoimmunogenic human pluripotent stem cells are valid cell sources for cell therapeutics with normal self-renewal and multilineage differentiation capacity
inferred← citeshttps://doi.org/10.1360/ssv-2024-0301openalex-snapshot
Research progress on chemical reprogramming for inducing human pluripotent stem cells
inferred← citeshttps://doi.org/10.15283/ijsc23037openalex-snapshot
Expression of Major Histocompatibility Complex during Neuronal Differentiation of Somatic Cell Nuclear Transfer-Human Embryonic Stem Cells
inferred← citeshttps://doi.org/10.21873/anticanres.11703openalex-snapshot
Application of Cancer Cell Reprogramming Technology to Human Cancer Research
inferred← citeshttps://doi.org/10.2217/rme-2016-0057openalex-snapshot
Making it Personal: The Prospects for Autologous Pluripotent Stem Cell-Derived Therapies
inferred← citeshttps://doi.org/10.2217/rme-2016-0102openalex-snapshot
Cell Therapies For Parkinson'S Disease: How Far Have We Come?
inferred← citeshttps://doi.org/10.2337/db16-1406openalex-snapshot
Autologous Pluripotent Stem Cell–Derived β-Like Cells for Diabetes Cellular Therapy
inferred← citeshttps://doi.org/10.3390/biology14070791openalex-snapshot
Macrophage Migration Inhibitory Factor Suppresses Natural Killer Cell Response and Promotes Hypoimmunogenic Stem Cell Engraftment Following Spinal Cord Injury
inferred← citeshttps://doi.org/10.3390/cells11111853openalex-snapshot
Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy
inferred← citeshttps://doi.org/10.3390/cells14161248openalex-snapshot
Hypoimmunogenic Human iPSCs for Repair and Regeneration in the CNS
inferred← citeshttps://doi.org/10.3390/cells5040044openalex-snapshot
Potential of Induced Pluripotent Stem Cells (iPSCs) for Treating Age-Related Macular Degeneration (AMD)
inferred← citeshttps://doi.org/10.3390/ijms21228685openalex-snapshot
Diabetes Mellitus Is a Chronic Disease that Can Benefit from Therapy with Induced Pluripotent Stem Cells
inferred← citeshttps://doi.org/10.3390/molecules27165089openalex-snapshot
Recent Advances in Age-Related Macular Degeneration Therapies
inferred← citeshttps://doi.org/10.6084/m9.figshare.20023175openalex-snapshot
Additional file 1 of Changes in best-corrected visual acuity in patients with dry age-related macular degeneration after stem cell transplantation: systematic review and meta-analysis
inferred← citeshttps://doi.org/10.6084/m9.figshare.22609745openalex-snapshot
Additional file 1 of Hypoimmunogenic human pluripotent stem cells are valid cell sources for cell therapeutics with normal self-renewal and multilineage differentiation capacity
inferred← citeshttps://doi.org/10.70675/35488587za140z4e03z9741z325e59949c86openalex-snapshot
Reconstruction cornéenne : traitement des déficiences en cellules souches limbiques totales et bilatérales associées ou non à une atteinte du stroma
inferred← citeshttps://doi.org/10.70675/ac4516a9z0ec1z4655z97daz547d512b3fc9openalex-snapshot
Hépatocytes différenciés à partir de cellules souches pluripotentes induites : modèle pour la thérapie cellulaire et génique autologue de l'hémophilie B et modèle préclinique chez le primate
inferred← citeshttps://doi.org/10.7551/mitpress/10837.001.0001openalex-snapshot
The Future of Brain Repair
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.